By Genalyn Kabiling
President Duterte will take into consideration the Senate report on the Dengvaxia controversy in crafting the government’s future course of action, Malacañang said today.
Presidential spokesman Harry Roque said the President would also wait for the findings of the investigation conducted by the National Bureau of Investigation (NBI) on the controversial government vaccination program.
“On Senate Report on Dengvaxia: That’s a report created by a powerful committee of a coequal branch of government that will be given much weight by the Executive when it decides its next course of action on the issue,” Roque said in a message to reporters.
“The President though is still awaiting the report of the NBI on the matter,” he added.
A draft Senate committee report found former President Benigno Aquino III, former Health Secretary Janette Garin, and other officials “criminally liable” for the alleged irregular procurement of P3.5 billion worth of the dengue vaccine.
The panel report, released by Senate Blue Ribbon committee chair Sen. Richard Gordon, claimed that purchase of the Dengvaxia from French pharmaceutical firm Sanofi Pasteur was done with “undue haste.”
It also recommended the filing of charges against Sanofi Pasteur for allegedly selling a defective product, and endangering the lives of children injected with Dengvaxia.